69: Central Venous Catheter Site Care

Published on 06/03/2015 by admin

Filed under Critical Care Medicine

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1214 times

PROCEDURE 69

Central Venous Catheter Site Care

PATIENT ASSESSMENT AND PREPARATION

Patient Assessment

References

1. Balamongkhon, B, Thamlikitkul, V. Implementation of chlorhexidine gluconate for central venous catheter site care at Siriraj Hospital, BangkokThailand. Am J Infect Control. 2007; 35:585–588.

image 2. Chaiyakunapruk, N, Veenstra, DL, Lipsky, BA, et al, Chlorhexidine compared with povidone-iodine solution for vascular catheter-site care. a meta-analysis. Ann Intern Med 2002; 136:792–807.

image 3. Eggimann, P, Harbarth, S, Constantin, M. Impact of a prevention strategy targeted at vascular-access care on incidence of infections acquired in intensive care. Lancet. 2000; 355:1864–1868.

4. Infusion Nurses Society. Infusion nursing standards of practice. J Infus Nurs. 2006; 29:S1–S92.

5. Maenthaisong, R, Chaiyakunapruk, N, Visanu, T. Cost–effective analysis of chlorhexidine gluconate compared with povidone-iodine solution for catheter-site care in Siriraj -HospitalThailand. J Med Assoc Thai. 2006; 89:S94–S101.

image 6. Maki, DG, Narans, LL, Knasinski, V, et al. Prospective, randomized, investigator-masked trial of novel chlohexidine-impregnated disk (Biopatch) on central venous and arterial catheters [abstract]. Infect Control Hosp Epidemiol. 2000; 21:96.

image 7. O’Grady, NP, et al. Guidelines for the prevention of intravascular catheter-related infections. Am J Infect Control. 2002; 30:89–476.

image 8. Safdar, N, Klugar, DM, Maki, DG, A review of risk factors for catheter-related bloodstream infection caused by percutaneously inserted, noncuffed central venous catheters. implications for preventive strategies. Medicine 2002; 81:466–472.